Tri Chemical Laboratories Inc. (4369) AI Stock Analysis

• Market Cap: ¥98.79B
• Dividend Yield: 1.15%
• Average Volume (3M): 280.97K
• Price to Earnings (P/E): 18.4
• Beta (1Y): 1.18
• Revenue Growth: 96.61%
• EPS Growth: 133.90%
• Country: JP
• Employees: 274
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Chemicals - Specialty
• EPS (TTM): 37.16
• Shares Outstanding: 32,498,640
• 10 Day Avg. Volume: 300,970
• 30 Day Avg. Volume: 280,973
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,360.50
• Price Target Upside: 10.54% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 70 Outperform
• Price Target: ¥3,421.00 ▲(12.53% Upside)

Tri Chemical Laboratories Inc. has a strong financial foundation with impressive revenue and profit growth, which is the most significant factor in its overall score. However, the technical indicators suggest a bearish trend, which weighs down the score. The valuation is reasonable but does not provide a compelling case for significant upside. The absence of recent earnings call data and notable corporate events means these factors do not influence the score.

Tri Chemical Laboratories Inc. Business Overview & Revenue Model

Company Description

Tri Chemical Laboratories Inc. is a company based in Japan that specializes in the development, manufacturing, and distribution of high-purity chemical materials. These materials are primarily utilized in the semiconductor and electronics industries, which require stringent quality standards and innovative solutions. The company is recognized for its advanced chemical technologies and commitment to quality, serving a diverse range of clients within the high-tech manufacturing sector.

How the Company Makes Money

Tri Chemical Laboratories Inc. generates revenue through the sale of its high-purity chemical products, which are essential in the production processes of semiconductors and electronic components. The company caters to a global clientele, including major semiconductor manufacturers, and derives income from both direct sales and long-term supply agreements. Key revenue streams include the production and distribution of chemical precursors, etchants, and other specialty chemicals. Tri Chemical Laboratories Inc. may also engage in strategic partnerships and collaborations with industry leaders to enhance its product offerings and market reach, contributing further to its financial performance.

Tri Chemical Laboratories Inc. Financial Statement Overview

Summary

Tri Chemical Laboratories Inc. exhibits strong financial performance with impressive revenue and profit growth, robust profitability margins, and effective equity utilization. The company maintains a solid equity base and low financial leverage, indicating strong financial health.

Income Statement

Tri Chemical Laboratories Inc. shows strong revenue growth with a significant increase from the previous year. The gross profit margin and net profit margin are robust, indicating effective cost management. The company also maintains healthy EBIT and EBITDA margins, reflecting strong operational performance.

Balance Sheet

The company has a solid equity base with a high equity ratio, which suggests financial stability. The debt-to-equity ratio is low, indicating low financial leverage and reduced risk. Return on Equity (ROE) is excellent, showing effective utilization of shareholders' equity.

Cash Flow

Operating cash flow is strong, indicating good cash generation from operations. However, there was a decline in free cash flow growth, signaling potential challenges in managing capital expenditures. The cash flow ratios relative to net income are healthy, reflecting efficient cash management.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	18.91B	11.25B	13.80B	11.57B	9.80B
Gross Profit	8.01B	4.09B	5.58B	4.84B	4.38B
EBITDA	6.63B	4.61B	7.42B	6.35B	5.17B
Net Income	4.96B	2.47B	4.83B	4.10B	3.38B
Balance Sheet
Total Assets	36.94B	31.86B	32.12B	28.29B	19.87B
Cash, Cash Equivalents and Short-Term Investments	9.44B	10.50B	11.14B	8.03B	1.70B
Total Debt	1.78B	2.40B	3.24B	4.28B	5.05B
Total Liabilities	5.36B	4.29B	6.24B	6.97B	7.27B
Stockholders Equity	31.59B	27.57B	25.88B	21.32B	12.60B
Cash Flow
Free Cash Flow	605.75M	1.19B	4.84B	2.71B	-872.24M
Operating Cash Flow	3.68B	2.97B	6.39B	3.64B	2.09B
Investing Cash Flow	-3.12B	-1.78B	-1.56B	-932.88M	-2.96B
Financing Cash Flow	-1.62B	-1.86B	-1.70B	3.59B	948.34M

Tri Chemical Laboratories Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3040.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Negative. The current price of 3040 is below the 20-day moving average (MA) of 3277.00, below the 50-day MA of 3172.04, and above the 200-day MA of 2997.26, indicating a neutral trend. The MACD of -45.92 indicates Positive momentum. The RSI at 39.30 is Neutral, neither overbought nor oversold. The STOCH value of 7.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4369.

Tri Chemical Laboratories Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4365	79 Outperform	¥61.48B	9.75		2.09%	-1.66%	-29.18%
4113	77 Outperform	¥20.18B	12.41		2.18%	7.57%	35.66%
4028	74 Outperform	¥96.17B	8.96		3.49%	8.46%	74.58%
4369	70 Outperform	¥98.79B	18.44		1.15%	96.61%	133.90%
4008	69 Neutral	¥63.81B	13.64		4.34%	0.32%	-43.10%
Sector *	61 Neutral	$10.08B	5.96	0.94%	3.00%	3.04%	-41.02%

Tri Chemical Laboratories Inc. Corporate Events

Tri Chemical Laboratories Reports Strong Q1 2025 Financial Growth

Tri Chemical Laboratories Inc. reported significant financial growth for the three months ended April 30, 2025, with net sales doubling and operating profit increasing by 157.6% compared to the previous year. This financial performance indicates a strong market position and potential positive implications for stakeholders, as the company maintains a robust capital adequacy ratio of 80.7% and forecasts continued growth in the fiscal year ending January 31, 2026.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Tri Chemical Laboratories Explores Joint Ventures in China

Tri Chemical Laboratories Inc. has signed a memorandum of understanding with Hefei ADChem Semi-Tech. Co., Ltd. to explore joint ventures in the Chinese semiconductor market. This collaboration aims to leverage ADChem’s technological capabilities and market presence in China, though it is expected to have minimal impact on Tri Chemical’s performance in the current fiscal year.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.